Systems and methods for controlling power in an electrosurgical probe

• US 6,245,065 B1
• Filed: 09/10/1998
• Issued: 06/12/2001
• Est. Priority Date: 09/10/1998
• Status: Expired due to Term

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Scimed Life Systems Incorporated (Boston Scientific Corporation)
• Inventors: Panescu, Dorin, Swanson, David K., Burnside, Robert
• Primary Examiner(s): Dvorak, Linda C. M.
• Assistant Examiner(s): GIBSON, ROY DEAN
• Application Number:
  US09/150,831
• Time in Patent Office: 1,006 Days
• Field of Search: 606/34, 606/38, 606/40, 606/41, 606/42, 606/49, 606/50
• US Class Current: 606/40
• CPC Class Codes: A61B 18/1206 Generators therefor
• CPC Class Codes: A61B 18/1492 having a flexible, catheter-like structure, e.g. for heart ablation A61B18/1477 takes precedence
• CPC Class Codes: A61B 2018/0016 Energy applicators arranged in a two- or three dimensional array
• CPC Class Codes: A61B 2018/00351 Heart
• CPC Class Codes: A61B 2018/00577 Ablation
• CPC Class Codes: A61B 2018/00654 with individual control of each of a plurality of energy emitting elements
• CPC Class Codes: A61B 2018/0069 using fuzzy logic
• CPC Class Codes: A61B 2018/00702 Power or energy
• CPC Class Codes: A61B 2018/00714 Temperature
• CPC Class Codes: A61B 2018/00726 Duty cycle
• CPC Class Codes: A61B 2018/00791 Temperature
• CPC Class Codes: A61B 2018/00797 measured by multiple temperature sensors
• CPC Class Codes: A61B 2018/00803 with temperature prediction
• CPC Class Codes: A61B 2018/00821 measured by a thermocouple
• CPC Class Codes: A61B 2018/00875 Resistance or impedance
• CPC Class Codes: A61B 2018/124 switching the output to different electrodes, e.g. sequentially
• CPC Class Codes: A61B 2018/1253 monopolar
• CPC Class Codes: A61B 2018/128 generating two or more frequencies
• CPC Class Codes: A61B 2018/1467 using more than two electrodes on a single probe

Abstract

Systems and methods for controlling the power supplied to an electrosurgical probe. The systems and methods may be used to monitor electrode-tissue contact, adjust power in response to a loss of contact, and apply power in such a manner that charring, coagulum formation and tissue popping are less likely to occur.

Claims

1. An apparatus for coagulating tissue, comprising:

a support element;

at least one energy transmission element on the support element;

a source of energy operably connected to the at least one energy transmission element and adapted to supply energy at a first frequency and a second frequency less than the first frequency; and

a control system, operably connected to the energy source, and adapted to monitor impedance at the at least one energy transmission element at the first frequency and the second frequency and to determine a relationship between the impedance at the first frequency and the impedance at the second frequency.

2. An apparatus as claimed in claim 1, wherein the control system is adapted to generate a signal in response to a detection of a predetermined relationship between the impedance at the first frequency and the impedance at the second frequency.

3. An apparatus as claimed in claim 1, wherein the predetermined relationship is the impedance at the first frequency being substantially equal to the impedance at the second frequency.

4. An apparatus as claimed in claim 1, wherein the control system is adapted to reduce the level of power supplied by the source of energy in response to a detection of a predetermined relationship between the impedance at the first frequency and the impedance at the second frequency.

5. An apparatus as claimed in claim 1, wherein the control system is adapted to monitor the impedance at the at least one energy transmission element at a plurality of frequencies between the first and second frequency and to generate an impedance versus frequency profile corresponding to the monitored impedances.

6. An apparatus as claimed in claim 1, wherein the at least one energy transmission element comprises at least one electrode.

7. An apparatus as claimed in claim 1, wherein the source of energy comprises a RF energy source.

8. An apparatus as claimed in claim 1, wherein the control system will not cause the energy source to provide energy at a level sufficient for coagulation until a detection of a predetermined relationship between the impedance at the first frequency and the impedance at the second frequency.

9. An apparatus as claimed in claim 1, wherein the predetermined relationship is indicative of a level of contact between the at least one energy transmission element and the tissue.

10. An apparatus as claimed in claim 1, wherein the predetermined relationship is indicative of tissue type.

11. An apparatus as claimed in claim 1, wherein the control system will cause the energy source to terminate energy delivery in response to a detection of a predetermined relationship between the impedance at the first frequency and the impedance at the second frequency.

12. A method of coagulating tissue, comprising the steps of:

attempting to place an energy transmission element in contact with tissue;

supplying the energy transmission element with energy at a first frequency;

monitoring the impedance at the energy transmission element at the first frequency;

supplying the energy transmission element with energy at a second frequency less than the first frequency;

monitoring the impedance at the energy transmission element at the second frequency; and

determining a relationship between the impedance measured at the first frequency and the impedance measured at the second frequency.

13. A method of coagulating tissue as claimed in claim 12, further comprising the step of:

generating a signal in response to a detection of a predetermined relationship between the impedance measured at the first frequency and the impedance measured at the second frequency.

14. A method of coagulating tissue as claimed in claim 12, further comprising the step of:

adjusting the supply of energy in response to a detection of a predetermined relationship between the impedance measured at the first frequency and the impedance measured at the second frequency.

15. A method of coagulating tissue as claimed in claim 12, further comprising the step of:

terminating the supply of energy in response to a detection of a predetermined relationship between the impedance measured at the first frequency and the impedance measured at the second frequency.

16. A user interface for a tissue coagulation system, the coagulation system including a control device operable in response to at least one input power parameter, the user interface comprising:

a power parameter input device operably connected to the control device; and

an indicator, operably connected to the control device, that produces an indication, which is not associated with any input power parameter, that a therapeutic lesion has been formed.

17. A user interface as claimed in claim 16, wherein the indicator produces an audible indication that a therapeutic lesion has been formed.

18. A user interface as claimed in claim 16, wherein the indicator produces a visual indication that a therapeutic lesion has been formed.

19. A user interface as claimed in claim 16, wherein the indicator produces an instruction to discontinue energy application.

20. A user interface as claimed in claim 16, wherein the indicator produces an indication that energy application has been discontinued.

21. A method of coagulating tissue, comprising the steps of:

monitoring tissue being coagulated during a coagulation procedure;

collecting tissue data concerning at least one aspect of the monitored tissue;

determining when a therapeutic lesion has been formed based on the collected tissue data; and

providing at least one of an audible indication and a visual indication that the therapeutic lesion has been formed.

22. A user interface for a tissue coagulation system, the coagulation system including a control device, the user interface comprising:

a duration of power application input device operably connected to the control device for input of a power application duration; and

a completed lesion indicator, operably connected to the control device, that produces an indication that a therapeutic lesion has been formed prior to expiration of the input power application duration.

23. A user interface as claimed in claim 22, further comprising:

a duration of power application indicator operably connected to the control device.

24. A method of coagulating tissue, comprising the steps of:

inputting a power application duration;

beginning power application to tissue;

determining whether a therapeutic lesion has been formed during power application prior to expiration of the input power application duration; and

providing an indication that the therapeutic lesion has been formed prior to the expiration of the input power application duration.